University of Surrey

Test tubes in the lab Research in the ATI Dance Research

First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial

Lee, SM, Khan, I, Upadhyay, S, Lewanski, C, Falk, S, Skailes, G, Marshall, E, Woll, PJ, Hatton, M, Lal, R , Jones, R, Toy, E, Chao, D, Middleton, G, Bulley, S, Ngai, Y, Rudd, R, Hackshaw, A and Boshoff, C (2012) First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial LANCET ONCOLOGY, 13 (11). pp. 1161-1170.

Full text not available from this repository.
Item Type: Article
Authors :
NameEmailORCID
Lee, SM
Khan, Ii.khan@surrey.ac.uk
Upadhyay, S
Lewanski, C
Falk, S
Skailes, G
Marshall, E
Woll, PJ
Hatton, M
Lal, R
Jones, R
Toy, E
Chao, D
Middleton, G
Bulley, S
Ngai, Y
Rudd, R
Hackshaw, A
Boshoff, C
Date : 1 November 2012
Identification Number : 10.1016/S1470-2045(12)70412-6
Uncontrolled Keywords : Science & Technology, Life Sciences & Biomedicine, Oncology, ONCOLOGY, GROWTH-FACTOR RECEPTOR, METASTATIC COLORECTAL-CANCER, PERFORMANCE STATUS, STANDARD CHEMOTHERAPY, OPEN-LABEL, RASH, MULTICENTER, COMBINATION, GEFITINIB, CETUXIMAB
Related URLs :
Depositing User : Symplectic Elements
Date Deposited : 17 May 2017 10:40
Last Modified : 17 May 2017 10:40
URI: http://epubs.surrey.ac.uk/id/eprint/828759

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year


Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800